Read the online version.

.
FDA Emergency Use Authorization
Understanding Vaccine Safety, Availability, and Cost

Cigna is committed to keeping our clients, customers, and partners informed about the vaccine. As you are probably aware, the FDA issued an Emergency Use Authorization (EUA) for Pfizer’s COVID-19 vaccine and we expect a second EUA for Moderna’s vaccine to be issued shortly after December 17.

In the weeks and months ahead, we will:

  • Provide information about the safety and efficacy of the vaccine and answer questions as they arise. Through education, we hope to increase vaccine acceptance rates so that we can put an end to the COVID-19 pandemic.
  • Send targeted communications to customers during different phases of availability to encourage vaccination.
  • Do all we can to address and eliminate healthcare disparities related to COVID-19 vaccinations.
  • Continue to drive affordability so customers have no out-of-pocket cost for the vaccine or administration cost. Vaccine is initially provided by government. The administration cost is paid for by the Cigna medical or prescription plan.
  • Inform members about options for getting vaccinated in their community as vaccines become readily available.
  • Apply to the CDC and State Health Departments to obtain vaccine on behalf of clients that have Cigna Onsite Health Centers.
  • Work with our vendor partners to better understand if and when COVID-19 vaccine events could potentially be held at client sites. This is of course dependent on vendors being able to obtain the vaccine and store it properly.

Early on, the COVID-19 vaccine supply will be limited, with the first doses designated for frontline healthcare workers and residents of long-term care facilities. Over the next three to four months we anticipate that vaccine supply will increase significantly and there will be opportunities for additional groups to be vaccinated.

We are committed to frequent two-way communications with our clients and will be in touch regularly with updates. We anticipate this to be a rapidly evolving situation with more vaccines potentially coming to market along with further guidance from the CDC and FDA. We are all in this together, so thank you for trusting Cigna.

Soon, we’ll share an email you can send to your workforce to offer vaccine information to help them prepare between now and when it’s their turn for a vaccination.

For more information, contact your Cigna representative.

Together, all the way.
All Cigna products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Cigna Behavioral Health, Inc., Life Insurance Company of North America, Cigna Life Insurance Company of New York (New York, NY), and HMO or service company subsidiaries of Cigna Health Corporation and Cigna Dental Health, Inc. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc.

954811 12/2020 © 2020 Cigna. Some content provided under license.


Legal Disclaimer  |  Privacy  |  Product Disclosures  | Cigna Company Names

 

© 2020 Cigna. All rights reserved